Novo Nordisk A/S (NVO): A Bull Case Theory [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk A/S (NVO)'s share was trading at $64.49 as of April 15 th . NVO's trailing and forward P/E were 18.76 and 15.41 respectively according to Yahoo Finance. A scientist in a lab, researching for a breakthrough treatment for Alzheimer's disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1 Diabetes. Novo Nordisk, a dominant player in the global pharmaceutical market, has achieved impressive financial success, largely driven by its blockbuster drug, Ozempic. However, as competition in the healthcare space intensifies and market dynamics shift, the key question is whether Novo can sustain its momentum or if it is overly reliant on a single product. Novo's business model is focused on pharmaceuticals for diabetes, obesity, and rare diseases, with diabetes care making up the largest share of its revenue. In 2024, the company reported total revenue of $40.6 billion, marking a 25% increase from the previous year. A significant portion of this growth is attributed to se
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- This Beaten-Down Stock Just Jumped By 8%. Time to Buy? [Yahoo! Finance]Yahoo! Finance
- Update: Market Chatter: Novo Nordisk Halves Prices of Obesity Drug in Parts of China [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk reportedly cut Wegovy prices in China by half [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk (NVO) Gets 9% Boost from Wegovy Pill OK [Yahoo! Finance]Yahoo! Finance
- The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website